Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v14-EN
Language English English
Date Updated 2022-02-12 2022-02-10
Drug Identification Number 02241411 02241411
Brand name UROMITEXAN UROMITEXAN
Common or Proper name MESNA MESNA
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients MESNA MESNA
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration ORAL INTRAVENOUS ORAL INTRAVENOUS ORAL INTRAVENOUS ORAL INTRAVENOUS
Packaging size 400mg / 4mL (2639B2019) 400mg / 4mL (2639B2019)
ATC code V03AF V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2022-01-06 2022-01-06
Actual start date 2022-01-06 2022-01-06
Estimated end date 2022-02-11 2022-02-11
Actual end date 2022-02-11 2022-02-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments